<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="review-article" dtd-version="1.0" xml:lang="HR" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">LV</journal-id>
<journal-id journal-id-type="nlm-ta">Lijec Vjesn</journal-id>
<journal-title-group>
<journal-title>Lijecnicki Vjesnik</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Lijec. Vjesn.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">0024-3477</issn>
<issn pub-type="epub">1849-2177</issn>
<publisher><publisher-name>Croatian Medical Association</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">LV-142-75</article-id>
<article-id pub-id-type="doi">10.26800/LV-142-3-4-13</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Guidelines</subject></subj-group>
</article-categories>
<title-group>
<article-title>ESPEN-ovo stru&#x010D;no mi&#x0161;ljenje i prakti&#x010D;ne smjernice za nutritivnu potporu bolesnika s infekcijom SARS-CoV-2*</article-title>
<trans-title-group xml:lang="en">
<trans-title>ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4049-2404</contrib-id><name><surname>Barazzoni</surname><given-names>Rocco</given-names></name><xref ref-type="fn" rid="afn1">*</xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bischoff</surname><given-names>Stephan C.</given-names></name><xref ref-type="fn" rid="afn1">*</xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Breda</surname><given-names>Joao</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wickramasinghe</surname><given-names>Kremlin</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Krznari&#x0107;</surname><given-names>&#x017D;eljko</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nitzan</surname><given-names>Dorit</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pirlich</surname><given-names>Matthias</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Singer</surname><given-names>Pierre</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><collab>uz podr&#x0161;ku ESPEN-ovog vije&#x0107;a</collab></contrib>
<aff id="aff1"><label>1</label>Department of Medical, Surgical and Health Sciences, <institution>University of Trieste</institution>, <country>Italy</country></aff>
<aff id="aff2"><label>2</label>Institute of Nutritional Medicine, <institution>University of Hohenheim</institution>, <addr-line>Stuttgart</addr-line>, <country>Germany</country></aff>
<aff id="aff3"><label>3</label>WHO European Office for Prevention and Control of Noncommunicable Diseases, <institution>WHO Regional Office for Europe</institution>, <addr-line>Moscow</addr-line>, <country>Russian Federation</country></aff>
<aff id="aff4"><label>4</label>Zavod za gastroenterologiju, hepatologiju i Odjel za klini&#x010D;ku prehranu, Klinika za unutra&#x0161;nje bolesti, Medicinski fakultet Sveu&#x010D;ili&#x0161;ta u Zagrebu, KBC Zagreb, Hrvatska</aff>
<aff id="aff5"><label>5</label>Health Emergencies and Operation Management, World Health Organization <italic>(WHO) Regional Office for Europe, Copenhagen, Denmark</italic></aff>
<aff id="aff6"><label>6</label>Imperial Oak Outpatient Clinic, Endocrinology, <institution>Gastroenterology &amp; Clinical Nutrition</institution>, <addr-line>Berlin</addr-line>, <country>Germany</country></aff>
<aff id="aff7"><label>7</label>Department of General Intensive Care and Institute for Nutrition Research, Rabin Medical Center, Beilinson Hospital, Sackler School of Medicine, <institution>Tel Aviv University</institution>, <addr-line>Tel Aviv</addr-line>, <country>Israel</country></aff>
</contrib-group>
<author-notes>
<fn id="afn1"><label>*</label><p>Jednako su doprinijeli rukopisu.</p></fn>
<corresp id="cor1">Adresa za dopisivanje: Prof. Rocco Barazzoni, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-4049-2404">https://orcid.org/0000-0002-4049-2404</ext-link> Dept. of Medical Sciences &#x2013; University of Trieste, Strada di Fiume, 447, 34149, Trieste, Italy, e-po&#x0161;ta: <email xlink:href="barazzon@units.it">barazzon@units.it</email></corresp></author-notes>
<pub-date pub-type="epub-ppub"><month>05</month><year>2020</year></pub-date>
<volume>142</volume>
<issue>3-4</issue>
<fpage>75</fpage>
<lpage>84</lpage>
<permissions>
<copyright-year>2020</copyright-year>
<copyright-holder>Croatian Medical Association</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" specific-use="CC BY-NC-ND 4.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.</license-p></license>
</permissions>
<abstract>
<title>SA&#x017D;ETAK</title>
<p>Pandemija infekcije COVID-19 predstavlja nevi&#x0111;ene izazove i prijetnje za pacijente i zdravstvene sustave u cijelome svijetu. Akutne respiratorne komplikacije koje zahtijevaju lije&#x010D;enje u jedinicama intenzivnog lije&#x010D;enja (JIL) glavni su uzrok pobola i smrtnosti kod pacijenata sa infekcijom COVID-19. Pacijenti s najlo&#x0161;ijim ishodima i ve&#x0107;om smrtno&#x0161;&#x0107;u su imunokompromitirani bolesnici, posebice starije dobi te polimorbidni, kao i pothranjeni bolesnici. Trajanje boravka u JIL-u, polimorbiditet i starija dob obi&#x010D;no su povezani s visokim rizikom pothranjenosti, &#x0161;to je samo po sebi relevantan &#x010D;imbenik rizika za ve&#x0107;i pobol i smrtnost u bolesnika s kroni&#x010D;nim i akutnim bolestima. Za bolesnike s infekcijom COVID-19 &#x010D;esto je potreban produljeni boravak u JIL-u u svrhu stabilizacije, a to mo&#x017E;e izravno uzrokovati ili pogor&#x0161;ati malnutriciju, uz pridru&#x017E;eni gubitak skeletne mi&#x0161;i&#x0107;ne mase i funkcije koji vode ka invaliditetu, smanjenoj kvaliteti &#x017E;ivota i dodatnom morbiditetu. Prevenciju, dijagnozu i lije&#x010D;enje malnutricije stoga treba rutinski uklju&#x010D;iti u lije&#x010D;enje bolesnika s infekcijom COVID-19. U ovome dokumentu Europsko dru&#x0161;tvo za klini&#x010D;ku prehranu i metabolizam (ESPEN) ima za cilj pru&#x017E;iti sa&#x017E;ete smjernice za nutritivnu potporu bolesnika s COVID-19 te predla&#x017E;e 10 prakti&#x010D;nih preporuka. Prakti&#x010D;ne smjernice usmjerene su na bolesnike u JIL-u ili u slu&#x010D;aju starije dobi i polimorbiditeta, koji su neovisno povezani s malnutricijom i njezinim negativnim utjecajem na pre&#x017E;ivljavanje bolesnika.</p>
</abstract>
<trans-abstract xml:lang="en">
<title>SUMMARY</title>
<p>The COVID-19 pandemics is posing unprecedented challenges and threats to patients and healthcare systems worldwide. Acute respiratory complications that require intensive care unit (ICU) management are a major cause of morbidity and mortality in COVID-19 patients. Patients with worst outcomes and higher mortality are reported to include immunocompromised subjects, namely older adults and polymorbid individuals and malnourished people in general. ICU stay, polymorbidity and older age are all commonly associated with high risk for malnutrition, representing per se a relevant risk factor for higher morbidity and mortality in chronic and acute disease. Also importantly, prolonged ICU stays are reported to be required for COVID-19 patients stabilization, and longer ICU stay may per se directly worsen or cause malnutrition, with severe loss of skeletal muscle mass and function which may lead to disability, poor quality of life and additional morbidity. Prevention, diagnosis and treatment of malnutrition should therefore be routinely included in the management of COVID-19 patients. In the current document, the European Society for Clinical Nutrition and Metabolism (ESPEN) aims at providing concise guidance for nutritional management of COVID-19 patients by proposing 10 practical recommendations. The practical guidance is focused to those in the ICU setting or in the presence of older age and polymorbidity, which are independently associated with malnutrition and its negative impact on patient survival.</p>
</trans-abstract>
<kwd-group kwd-group-type="author"><kwd>Deskriptori BETAKORONAVIRUS</kwd><kwd>INFEKCIJE KORONAVIRUSOM &#x2013; komplikacije, lije&#x010D;enje</kwd><kwd>RESPIRACIJSKA INSUFICIJENCIJA &#x2013; etiologija, lije&#x010D;enje</kwd><kwd>MALNUTRICIJA &#x2013; dijagnoza, lije&#x010D;enje, prevencija</kwd><kwd>PROCJENA NUTRITIVNOG STATUSA</kwd><kwd>PREHRAMBENI DODACI</kwd><kwd>NUTRITIVNA POTPORA &#x2013; metode</kwd><kwd>INTENZIVNO LIJE&#x010C;ENJE &#x2013; metode</kwd><kwd>JEDINICE INTENZIVNE SKRBI</kwd><kwd>NEINVAZIVNA VENTILACIJA</kwd><kwd>MEHANI&#x010C;KA VENTILACIJA</kwd><kwd>EKSTUBACIJA &#x2013; ne&#x017E;eljeni u&#x010D;inci</kwd><kwd>SMETNJE GUTANJA &#x2013; etiologija</kwd><kwd>TJELESNA AKTIVNOST</kwd><kwd>MI&#x0160;I&#x0106;NA SLABOST</kwd><kwd>KARANTENA</kwd><kwd>MEDICINSKA DRU&#x0160;TVA</kwd><kwd>EUROPA</kwd><kwd>SMJERNICE</kwd></kwd-group>
<kwd-group kwd-group-type="translator" xml:lang="en"><title>Descriptors </title><kwd>BETACORONAVIRUS</kwd><kwd>CORONAVIRUS INFECTIONS &#x2013; complications, therapy</kwd><kwd>RESPIRATORY INSUFFICIENCY &#x2013; etiology, therapy</kwd><kwd>MALNUTRITION &#x2013; diagnosis, prevetion and control, therapy</kwd><kwd>NUTRITION ASSESSMENT</kwd><kwd>DIETARY SUPPLEMETNS</kwd><kwd>NUTRITIONAL SUPPORT &#x2013; methods</kwd><kwd>CRITICAL CARE &#x2013;methods</kwd><kwd>INTENSIVE CARE UNITS</kwd><kwd>NONINVASIVE VENTILATION</kwd><kwd>RESPIRATION, ARTIFICIAL</kwd><kwd>AIRWAY EXTUBATION &#x2013; adverse effects</kwd><kwd>DEGLUTITION DISORDERS &#x2013; etology</kwd><kwd>EXERCISE</kwd><kwd>MUSCLE WEAKNESS</kwd><kwd>QUARANTINE</kwd><kwd>SOCIETIES, MEDICAL</kwd><kwd>EUROPE</kwd><kwd>PRACTICE GUIDELINES AS TOPIC</kwd></kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="other1">
<title>Uvod</title>
<p>Izbijanje pandemije COVID-19 predstavlja nevi&#x0111;ene izazove i prijetnje za bolesnike i zdravstvene sustave &#x0161;irom svijeta (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>&#x2013;<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>). Bolest zahva&#x0107;a primarno respiratorni sustav (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>&#x2013;<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>), ali mo&#x017E;e se pogor&#x0161;ati do multiorganskog zatajenja i zavr&#x0161;iti smr&#x0107;u<sup>3</sup>. Akutne respiratorne komplikacije za koje se navodi da zahtijevaju produ&#x017E;eni boravak u JIL-u glavni su uzrok pobola i smrtnosti u bolesnika s COVID-19, a osobe starije dobi i polimorbidni bolesnici imaju najgore ishode i ve&#x0107;u smrtnost (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>&#x2013;<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>). Boravak u JIL-u, posebice kada je produljenog trajanja, neovisan je &#x010D;imbenik rizika za pojavu malnutricije, pra&#x0107;ene gubitkom skeletne mi&#x0161;i&#x0107;ne mase i funkcije te vodi dugoro&#x010D;no ka lo&#x0161;ijoj kvaliteti &#x017E;ivota, invalidnosti i pobolu nakon otpu&#x0161;tanja iz JIL-a (<xref ref-type="bibr" rid="r6"><italic>6</italic></xref>).</p>
<p>Mnoge kroni&#x010D;ne bolesti poput dijabetesa i kardiovaskularnih bolesti kao i njihova istodobna prisutnost u polimorbidnih bolesnika (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>) te u starijoj &#x017E;ivotnoj dobi (<xref ref-type="bibr" rid="r8"><italic>8</italic></xref>) tako&#x0111;er su vrlo &#x010D;esto povezane s visokim rizikom i prevalencijom pothranjenosti i lo&#x0161;ijim ishodima. Uzroci pothranjenosti povezane s JIL-om i bole&#x0161;&#x0107;u uklju&#x010D;uju smanjenu pokretljivost i kataboli&#x010D;ke promjene, posebice u skeletnom mi&#x0161;i&#x0107;ju, kao i smanjen unos hrane, a sve se to mo&#x017E;e dodatno pogor&#x0161;ati u osoba starije dobi (<xref ref-type="bibr" rid="r6"><italic>6</italic></xref>&#x2013;<xref ref-type="bibr" rid="r8"><italic>8</italic></xref>). Osim toga, razvoj upale i sepse mogu dodatno potaknuti sve ranije navedene nepo&#x017E;eljne promjene u prisutnosti SARS-CoV-2 infekcije. Provedba adekvatne i pravovremene procjene nutritivnog statusa te odgovaraju&#x0107;e lije&#x010D;enje u&#x010D;inkovito smanjuju komplikacije i pobolj&#x0161;avaju relevantne klini&#x010D;ke ishode u razli&#x010D;itim uvjetima, uklju&#x010D;uju&#x0107;i trajanje boravka u JIL-u, hospitalizacije, vi&#x0161;e kroni&#x010D;nih bolesti i kod starije dobi (<xref ref-type="bibr" rid="r6"><italic>6</italic></xref>&#x2013;<xref ref-type="bibr" rid="r8"><italic>8</italic></xref>).</p>
<p>Temeljem ranije navedenih zapa&#x017E;anja potrebno je provoditi prevenciju, dijagnostiku i lije&#x010D;enje pothranjenosti u ovih bolesnika kako bi se pobolj&#x0161;ala kratkoro&#x010D;na i dugoro&#x010D;na prognoza te klini&#x010D;ki ishodi.</p>
<p>U ovome dokumentu Europsko dru&#x0161;tvo za klini&#x010D;ku prehranu i metabolizam (ESPEN) ima za cilj pru&#x017E;iti sa&#x017E;ete smjernice stru&#x010D;ne skupine i prakti&#x010D;ne smjernice o nutritivnoj potpori bolesnika s COVID-19, s posebnim osvrtom na bolesnike u JIL-u ili u prisutnosti starije dobi ili komorbiditeta, koji predstavljaju neovisne &#x010D;imbenike rizika za pojavu malnutricije i ve&#x0107;u smrtnost. Preporuke se temelje na trenutno va&#x017E;e&#x0107;im ESPEN-ovim smjernicama i dodatnim stru&#x010D;nim savjetima. Budu&#x0107;i da ne postoje specifi&#x010D;ne klini&#x010D;ke studije o prehrani bolesnika s COVID-19, smjernice se mogu temeljiti isklju&#x010D;ivo na dosada&#x0161;njim klini&#x010D;kim znanjima i najboljoj klini&#x010D;koj praksi.</p>
</sec>
<sec sec-type="other2">
<title>Prevencija i lije&#x010D;enje malnutricije u osoba izlo&#x017E;enih riziku ili u bolesnika s infekcijom SARS-CoV-2</title>
<sec>
<title>Preporuka 1</title>
<p>Bolesnicima koji su u riziku od lo&#x0161;ih ishoda i ve&#x0107;e smrtnosti uslijed infekcije SARS-CoV-2, posebice kod starijih osoba te polimorbidnih bolesnika, potrebno je provesti probir i procjenu nutritivnog statusa. Ova procjena u po&#x010D;etku se treba temeljiti na kriterijima sadr&#x017E;anim u upitniku MUST*, a za hospitalizirane bolesnike na NRS-2002** kriterijima za probir pothranjenosti.</p>
<list id="L1" list-type="bullet"><list-item><p>MUST kriteriji: <ext-link ext-link-type="uri" xlink:href="https://www.bapen.org.uk/screening-and-must/must-calculator">https://www.bapen.org.uk/screening-and-must/must-calculator</ext-link></p></list-item>
<list-item><p>* NRS-2002 kriteriji: <ext-link ext-link-type="uri" xlink:href="https://www.mdcalc.com/nutrition-risk-screening-2002-nrs-2002">https://www.mdcalc.com/nutrition-risk-screening-2002-nrs-2002</ext-link></p></list-item></list>
<p>Identifikacija rizika i prisutnosti pothranjenosti trebala bi biti prvi korak u procjeni svih bolesnika, s posebnim naglaskom na rizi&#x010D;ne kategorije bolesnika, uklju&#x010D;uju&#x0107;i osobe starije dobi i oboljele od kroni&#x010D;nih i akutnih bolesti.</p>
<p>Budu&#x0107;i da je pothranjenost definirana ne samo niskom tjelesnom masom, nego i nesposobno&#x0161;&#x0107;u odr&#x017E;anja adekvatnog sastava tijela i skeletne mi&#x0161;i&#x0107;ne mase, pretile osobe treba procijeniti prema istim kriterijima.</p>
<p>Alati za probir nutritivnog rizika poput klini&#x010D;kih alata MUST ili NRS-2002 u dugotrajnoj su primjeni i validirani su u op&#x0107;oj klini&#x010D;koj praksi ili u specifi&#x010D;nim bolestima i uvjetima probira. Za opse&#x017E;niju procjenu nutritivnog statusa bolesnika u nutritivnom riziku razvijeni su razli&#x010D;iti alati. To su primjerice SGA ili subjektivna globalna procjena, MNA ili <italic>Mini Nutritional Assessment</italic> posebno namijenjen gerijatrijskim bolesnicima te <italic>NUTRIC score</italic> &#x2013; kriteriji razvijeni za bolesnike u JIL-u (<xref ref-type="bibr" rid="r8"><italic>8</italic></xref>, <xref ref-type="bibr" rid="r9"><italic>9</italic></xref>). GLIM (<italic>Global Leadership Initiative on Malnutrition</italic>) kriteriji su za procjenu pothranjenosti koji su objavljeni nedavno te su ih prihvatila brojna stru&#x010D;na dru&#x0161;tva za klini&#x010D;ku prehranu &#x0161;irom svijeta (<xref ref-type="bibr" rid="r10"><italic>10</italic></xref>). GLIM predla&#x017E;e pristup dijagnozi pothranjenosti u dva koraka. U prvom koraku provodi se probir pacijenata &#x201E;u riziku&#x201C; kori&#x0161;tenjem validiranih alata poput MUST ili NRS-2002, a u drugom koraku provodi se procjena u svrhu stupnjevanja malnutricije (<xref ref-type="table" rid="t1">Table 1</xref>). Prema GLIM kriterijima, dijagnoza malnutricije zahtijeva barem jedan fenotipski kriterij i jedan etiolo&#x0161;ki kriterij.</p>
<table-wrap id="t1" position="float">
<label>Table 1</label><caption><title>Fenotipski i etiolo&#x0161;ki kriteriji za dijagnozu malnutricije, adaptirani prema (<xref ref-type="bibr" rid="r9"><italic>9</italic></xref>).</title>
</caption>
<table frame="hsides" rules="groups">
<col width="18.3%"/>
<col width="30.5%"/>
<col width="23.16%"/>
<col width="28.04%"/>
<thead>
<tr>
<th valign="middle" colspan="2" align="left" scope="colgroup" style="border-left: solid 0.75pt; border-top: solid 0.75pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt">Fenotipski kriteriji</th>
<th valign="middle" colspan="2" align="left" scope="colgroup" style="border-left: solid 0.50pt; border-top: solid 0.75pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt">Etiolo&#x0161;ki kriteriji</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row">Gubitak tjelesne mase (%)</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt">&gt;5% u posljednjih 6 mjeseci ili &gt;10% u vi&#x0161;e od 6 mjeseci</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt">Smanjen unos hrane ili smanjena asimilacija**</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.75pt; border-bottom: solid 0.50pt">50% EP &gt; 1 tjedna, ili smanjenje &gt;2 tjedna, ili bilo koje kroni&#x010D;ne GI bolesti koje negativno utje&#x010D;u na apsorpciju ili digestiju hrane</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row">Nizak indeks tjelesne mase (kg/m<sup>2</sup>)</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt">&lt;20 ako je bolesnik &lt;70 godina, ili &lt;22 ako je &gt;70 godina<break/>Azija:<break/>&lt;18,5 ako je &lt;70 godina, ili &lt;20 ako je &gt;70 godina</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt">Upala***</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.75pt; border-bottom: solid 0.50pt">Povezana s akutnom bolesti ili ozljedom odnosno kroni&#x010D;nom bolesti</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.75pt" scope="row">Smanjena mi&#x0161;i&#x0107;na masa</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.75pt">Smanjenje dijagnosticirano nekim od validiranih tehnika mjerenja sastava tijela*</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.75pt"></td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.75pt; border-bottom: solid 0.75pt"></td>
</tr>
</tbody>
</table><table-wrap-foot>
<p>Kratice: GI, gastrointestinalne; EP, energetske potrebe.</p>
<p>* Mi&#x0161;i&#x0107;na masa mo&#x017E;e se procijeniti uz pomo&#x0107; DEXA, BIA, CT ili MRI. Alternativno, koriste se uvrije&#x017E;ena antropometrijska mjerenja &#x2013; mjerenje opsega nadlaktice ili potkoljenice (pogledati: <ext-link ext-link-type="uri" xlink:href="https://nutritionalassessment.mumc.nl/en/anthropometry">https://nutritionalassessment.mumc.nl/en/anthropometry</ext-link>). Grani&#x010D;ne vrijednosti za smanjenu mi&#x0161;i&#x0107;nu masu treba adaptirati u skladu s rasom (Azija). Funkcionalna procjena poput dinamometrije &#x0161;ake tako&#x0111;er se treba razmotriti.</p>
<p>** Razmotriti gastrointestinalne simptome kao dodatne indikatore koji mogu ugroziti prehrambeni unos ili apsorpciju, npr. disfagija, mu&#x010D;nina, povra&#x0107;anje, proljev, konstipacija ili abdominalna bol. Smanjena asimilacija hrane / nutrijenata povezana je s malapsorpcijskim bolestima poput sindroma kratkog crijeva, insuficijencije pankreasa te nakon barijatrijske kirurgije. Treba uzeti u obzir i ezofagealne strikture, gastroparezu i intestinalnu pseudo-opstrukciju.</p>
<p>*** Akutne bolesti / ozljede: te&#x0161;ka upala povezana je s te&#x0161;kom infekcijom, opeklinama, traumom ili ozljedom glave. Kroni&#x010D;ne bolesti: kroni&#x010D;na ili rekurentna blaga do umjerena upala mo&#x017E;e biti povezana s malignim bolestima, kroni&#x010D;nom opstruktivnom bolesti plu&#x0107;a, kongestivnim zatajenjem srca, kroni&#x010D;nim bolestima bubrega ili bilo kojom bolesti koja se javlja uz kroni&#x010D;nu ili rekurentnu upalu. Prolazna upala niskog stupnja ne uklapa se u ovaj etiolo&#x0161;ki kriterij. C-reaktivni protein mo&#x017E;e se koristiti kao laboratorijski parametar.</p>
</table-wrap-foot></table-wrap>
<p>Gore navedene napomene primjenjive su za bolesnike u riziku od te&#x0161;ke infekcije SARS-CoV-2 te za bolesnike hospitalizirane zbog te infekcije, budu&#x0107;i da su lo&#x0161;iji ishodi izvjesni za bolesnike kod kojih je prisutna malnutricija (poput osoba starije dobi ili s komorbiditetima). Odr&#x017E;anje primjerenoga nutritivnog statusa te prevencija ili terapija malnutricije posjeduju potencijal smanjenja komplikacija i negativnih ishoda u bolesnika s nutritivnim rizikom koji bi se mogli zaraziti s COVID-19. Nadalje, COVID-19 mo&#x017E;e biti pra&#x0107;en mu&#x010D;ninom, povra&#x0107;anjem i proljevom, &#x0161;to utje&#x010D;e na unos i apsorpciju hrane (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>), stoga je dobar nutritivni status prednost za osobe u riziku od te&#x0161;kog oblika infekcije COVID-19. U nedavno objavljenom preglednom radu o potencijalnim intervencijama za novi koronavirus, temeljenom na kineskim iskustvima, autori predla&#x017E;u da se svakom bolesniku s infekcijom procijeni nutritivni status prije uvo&#x0111;enja propisane terapije (<xref ref-type="bibr" rid="r11"><italic>11</italic></xref>). Prediktori mortaliteta mogu se identificirati multivarijantnom analizom na modelu influence, a to su: tip virusa (OR 7.1), malnutricija (OR 25.0), hospitalne infekcije (OR 12.2), respiratorna insuficijencija (OR 125.8) i plu&#x0107;ni infiltrat vidljiv na rendgenu (OR 118 6.0) (<xref ref-type="bibr" rid="r12"><italic>12</italic></xref>). Valja uzeti u obzir da su i pothranjena djeca u pove&#x0107;anom riziku od virusne pneumonije i potencijalno fatalnog ishoda infekcije. Primjerice, pokazano je da su pneumonija i malnutricija sna&#x017E;ni prediktori mortaliteta me&#x0111;u djecom hospitaliziranom zbog HIV infekcije (<xref ref-type="bibr" rid="r13"><italic>13</italic></xref>).</p>
</sec>
<sec>
<title>Preporuka 2</title>
<p>Pothranjene osobe trebaju optimizirati svoj nutritivni status, idealno putem nutritivnog savjetovanja s iskusnim profesionalcima (ovla&#x0161;tenim klini&#x010D;kim dijeteti&#x010D;arima, nutricionistima te lije&#x010D;nicima specijaliziranim za klini&#x010D;ku prehranu).</p>
<p>Retrospektivne analize podataka dostupnih o pandemiji gripe iz 1918. godine otkrile su da je te&#x017E;ina bolesti ovisila o &#x010D;imbenicima virusa i doma&#x0107;ina, odnosno zara&#x017E;ene osobe. Me&#x0111;u &#x010D;imbenicima vezanim za doma&#x0107;ina u smislu varijacija u pobolu i smrtnosti od gripe ulogu su igrali dob, stani&#x010D;ni i humoralni imunosni odgovori, genetika te na&#x010D;in prehrane (<xref ref-type="bibr" rid="r11"><italic>11</italic></xref>). Malnutricija i glad povezivani su s te&#x017E;om klini&#x010D;kom slikom bolesti i ve&#x0107;om smrtnosti i u mla&#x0111;oj populaciji oboljelih. Pothranjenost ostaje problem za virusne pandemije i u 21. stolje&#x0107;u. &#x0160;tovi&#x0161;e, smatra se da je kroni&#x010D;na malnutricija doprinijela pove&#x0107;anom pobolu i smrtnosti u djece u Gvatemali tijekom pandemijske gripe 2009. godine (<xref ref-type="bibr" rid="r12"><italic>12</italic></xref>).</p>
<p>U budu&#x0107;im virusnim pandemijama mo&#x017E;da &#x0107;emo se suo&#x010D;iti s &#x201E;dvostrukim teretom&#x201C; malnutricije, kada &#x0107;e i pothranjenost i prekomjerna tjelesna masa i pretilost utjecati na nastanak te&#x017E;ih oblika bolesti. Znanstveno je dokumentirano da pretilost pove&#x0107;ava rizik hospitalizacije i mortaliteta uslijed infekcije virusom gripe, a pretilost inhibira i za virus specifi&#x010D;ne CD8+ T stani&#x010D;ne odgovore i stvaranje antitijela na sezonsko cjepivo protiv gripe (<xref ref-type="bibr" rid="r11"><italic>11</italic></xref>). Izazov trenutne i budu&#x0107;ih pandemija stoga nije samo za&#x0161;tititi pothranjene bolesnike, nego i rastu&#x0107;i broj pretilih osoba (<xref ref-type="bibr" rid="r11"><italic>11</italic></xref>). To je posebno va&#x017E;no za europsku regiju Svjetske zdravstvene organizacije (SZO-a), jer u mnogim europskim zemljama pretilost i prekomjerna tjelesna masa poga&#x0111;aju 30&#x2013;70% stanovni&#x0161;tva (<xref ref-type="bibr" rid="r14"><italic>14</italic></xref>). U nedavno provedenoj japanskoj studiji pothranjenost i upala plu&#x0107;a identificirani su kao prognosti&#x010D;ki &#x010D;imbenici infekcije virusom influence, koji su podlo&#x017E;ni medicinskoj intervenciji. Koriste&#x0107;i Coxov regresijski model s odabranim neovisnim varijablama &#x2013; mu&#x0161;ki spol, te&#x017E;ina bolesti, razina albumina u serumu i upala plu&#x0107;a &#x2013; studija je pokazala povezanost s pre&#x017E;ivljavanjem 30 dana od po&#x010D;etka gripe (<xref ref-type="bibr" rid="r13"><italic>13</italic></xref>). Na&#x0161;e smjernice temeljimo na ranije objavljenim ESPEN-ovim smjernicama, s posebnim naglaskom na smjernicama za klini&#x010D;ku prehranu za polimorbidne pacijente (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>) i onima namijenjenim bolesnicima starije dobi (<xref ref-type="bibr" rid="r8"><italic>8</italic></xref>). &#x010C;itatelja upu&#x0107;ujemo na cjelovite smjernice za konkretne preporuke u raznim specifi&#x010D;nim uvjetima koji se mogu susresti u bolesnika s infekcijom COVID-19. Prisutnost barem dviju kroni&#x010D;nih bolesti kod iste osobe mo&#x017E;e se definirati kao polimorbiditet, a karakterizira je i pove&#x0107;an nutritivni rizik. Osobe starije dobi izlo&#x017E;ene su ve&#x0107;em riziku zbog kombinacija ve&#x0107;e prevalencije komorbiditeta, promjena u sastavu tijela povezanih sa starenjem s postupnim gubitkom skeletne mi&#x0161;i&#x0107;ne mase i funkcije (sarkopenija), s dodatnim &#x010D;imbenicima, uklju&#x010D;uju&#x0107;i oralne probleme, psiho-socijalna pitanja, kognitivna o&#x0161;te&#x0107;enja te lo&#x0161; financijski status. Pretili bolesnici starije dobi s kroni&#x010D;nim bolestima izlo&#x017E;eni su riziku smanjenja skeletne mi&#x0161;i&#x0107;ne mase i funkcije te ih je stoga potrebno u potpunosti uklju&#x010D;iti u gore navedene preporuke. Treba izbjegavati prehrambene preporuke koje poti&#x010D;u na ograni&#x010D;avanje prehrambenog unosa. Za bolesnike s infekcijom COVID-19 postupak savjetovanja mo&#x017E;e se provesti telekonferencijom, telefonom ili drugim sredstvima komuniciranja, ako je prikladno i mogu&#x0107;e, kako bi se smanjio rizik od infekcije djelatnika i &#x0161;irenja infekcije drugih pacijenata i osoblja.</p>
<p>Energetske potrebe mogu se izmjeriti primjenom indirektne kalorimetrije, ako je metoda dostupna (uz primjerenu sterilizaciju opreme), ili primjenom prediktivnih jednad&#x017E;bi temeljenih na tjelesnoj masi bolesnika poput ovih:</p>
<list id="L2" list-type="order"><list-item><p>27 kcal po kilogramu tjelesne mase na dan; ukupna energijska potro&#x0161;nja za polimorbidne bolesnike u dobi &gt;65 godina (preporuka 4.2 u referenci 7);</p></list-item>
<list-item><p>30 kcal po kilogramu tjelesne mase na dan; ukupna energijska potro&#x0161;nja za te&#x0161;ko pothranjene polimorbidne bolesnike (preporuka 4.3. u referenci 7)*;</p></list-item>
<list-item><p>30 kcal po kilogramu tjelesne mase na dan za bolesnike starije dobi; okvirna vrijednost energetskih potreba koju treba individualno prilagoditi sukladno nutritivnom status, stupnju tjelesne aktivnosti, stadiju bolesti i podno&#x0161;enju nutritivnog unosa (preporuka 1 u referenci 8).</p></list-item></list>
<p>* Cilj od 30 kcal/kg tjelesne mase u te&#x0161;ko pothranjenih bolesnika treba posti&#x0107;i pa&#x017E;ljivo i postupno, budu&#x0107;i da je ovo populacija u visokom riziku od <italic>refeeding</italic> sindroma (sindroma ponovne uspostave hranjenja).</p>
<p>Potrebe za proteinima obi&#x010D;no se izra&#x010D;unavaju putem formula poput sljede&#x0107;ih:</p>
<list id="L3" list-type="order"><list-item><p>1 g proteina po kilogramu tjelesne mase na dan u osoba starije dobi; koli&#x010D;inu treba individualno prilagoditi uzev&#x0161;i u obzir nutritivni status, stupanj tjelesne aktivnosti, stadij bolesti i podno&#x0161;enje nutritivnog unosa (preporuka 2 u referenci 8);</p></list-item>
<list-item><p>&#x2265; 1 g proteina po kilogramu tjelesne mase na dan u polimorbidnih hospitaliziranih bolesnika u svrhu prevencije gubitka tjelesne mase, smanjenja rizika komplikacija i ponovnih prijema u bolnicu (rehospitalizacija) te boljih ishoda (preporuka 5.1 u reference <xref ref-type="bibr" rid="r7">7</xref>).</p></list-item></list>
<p>Potrebe za mastima i ugljikohidratima uskla&#x0111;uju se s ukupnim energetskim potrebama uzev&#x0161;i u obzir preporu&#x010D;eni omjer masti i ugljikohidrata od 30:70 (bolesnici bez respiratorne insuficijencije), odnosno 50:50 (bolesnici na respiratoru, vidi dolje).</p>
</sec>
<sec>
<title>Preporuka 3</title>
<p>Pothranjene osobe trebaju osigurati odgovaraju&#x0107;u nadomjesnu primjenu vitamina i minerala.</p>
<p>Dio konvencionalnoga nutritivnog pristupa prevenciji virusnih infekcija jest suplementacija ili nadomjesna primjena vitamina kako bi se potencijalno smanjio negativni u&#x010D;inak bolesti (<xref ref-type="bibr" rid="r15"><italic>15</italic></xref>). Primjerice, nedostatak vitamina D povezuje se s razli&#x010D;itim virusnim bolestima koje uklju&#x010D;uju gripu ili influencu (<xref ref-type="bibr" rid="r16"><italic>16</italic></xref>&#x2013;<xref ref-type="bibr" rid="r19"><italic>19</italic></xref>), HIV (<xref ref-type="bibr" rid="r20"><italic>20</italic></xref>) i hepatitis C (<xref ref-type="bibr" rid="r21"><italic>21</italic></xref>), me&#x0111;utim, nisu sve studije suglasne kad je u pitanju influenca (<xref ref-type="bibr" rid="r22"><italic>22</italic></xref>, <xref ref-type="bibr" rid="r23"><italic>23</italic></xref>). COVID-19 prvi put je otkriven u zimu 2019. godine i naj&#x010D;e&#x0161;&#x0107;e su obolijevale osobe zrele i starije dobi. Budu&#x0107;a istra&#x017E;ivanja trebaju potvrditi je li nedostatak vitamina D &#x010D;e&#x0161;&#x0107;i u bolesnika s infekcijom COVID-19 i je li koncentracija 25-OH vitamina D u krvi bolesnika povezana s ishodom ove bolesti. U prilog ovoj hipotezi govore rezultati studije na animalnom modelu koji pokazuju da sni&#x017E;ena koncentracija vitamina D u krvi krava pove&#x0107;ava rizik infekcije koronavirusom u ovih &#x017E;ivotinja (<xref ref-type="bibr" rid="r24"><italic>24</italic></xref>).</p>
<p>Drugi primjer je vitamin A, kao poznati &#x201E;antiinfektivni&#x201C; vitamin, budu&#x0107;i da brojni sustavi obrane od infekcije ovise o primjerenoj opskrbi ovim vitaminom. Primjerice, nedostatak vitamina A povezuje se s ospicama (morbili) i proljevima, a ospice mogu pokazati te&#x0161;ku klini&#x010D;ku sliku u djece s nedostatkom vitamina A. Nadalje, postoje znanstveni dokazi koji ukazuju da nadomjesna primjena vitamina A smanjuje pobol i smrtnost u razli&#x010D;itim infektivnim bolestima poput ospica, proljeva, pneumonije izazvane ospicama, HIV infekcije i malarije. Suplementacija vitaminom A mo&#x017E;e pru&#x017E;iti izvjesnu za&#x0161;titu protiv drugih smrtonosnih bolesti uklju&#x010D;uju&#x0107;i malariju, infektivne bolesti plu&#x0107;a i HIV. Na eksperimentalnim modelima, utjecaj zaraze infektivnim virusom bronhitisa (IBV), vrste koronavirusa, bio je izra&#x017E;eniji u pili&#x0107;a hranjenih dijetom deficitarnom vitaminom A u usporedbi s pili&#x0107;ima hranjenim dijetom s primjerenom koli&#x010D;inom vitamina A (<xref ref-type="bibr" rid="r25"><italic>25</italic></xref>). Nadalje, opisano je da nadomjesna primjena vitamina A u ljudi smanjuje pobol i smrtnost od razli&#x010D;itih infektivnih bolesti poput ospica, infektivnih proljeva, pneumonije povezane s ospicama, malarije i infekcije HIV / AIDS. Pandemija COVID-19 ukazala je na pitanje kako infekcija SARS-CoV-2 utje&#x010D;e na osobe oboljele od HIV-a / AIDS-a. U bolesnika kod kojih se terapijski postupci za HIV / AIDS provode zadovoljavaju&#x0107;e, rizik komplikacija COVID-19 se ne pove&#x0107;ava. Me&#x0111;utim, u mnogim krajevima svijeta oboljeli od AIDS-a primaju suboptimalnu terapiju i skloniji su te&#x0161;kim komplikacijama. Postoje dokazi da primjerena nutritivna potpora za sve, a posebice za osobe koje &#x017E;ive s AIDS-om, mo&#x017E;e pospje&#x0161;iti otpornost prema drugim infekcijama uslijed ja&#x010D;anja imunosnog sustava (<xref ref-type="bibr" rid="r26"><italic>26</italic></xref>).</p>
<p>Op&#x0107;enito, niske razine ili nedovoljan unos mikronutrijenata poput vitamina A, E, B6 i B12, cinka i selena povezuju se s ne&#x017E;eljenim klini&#x010D;kim ishodima tijekom virusnih infekcija (<xref ref-type="bibr" rid="r27"><italic>27</italic></xref>). Ove postavke potvr&#x0111;ene su i u nedavno objavljenom pregledu autora Zhang i Yunhui Liu (<xref ref-type="bibr" rid="r15"><italic>15</italic></xref>) koji su predlo&#x017E;ili da se osim odre&#x0111;ivanja vitamina A i D razmotri i procjena statusa vitamina B kompleksa, vitamina C, omega-3 masnih kiselina, selena, cinka i &#x017E;eljeza u bolesnika s infekcijom COVID-19. Iako je va&#x017E;no prevenirati i sanirati deficite mikronutrijenata, ne postoje dokazi da rutinska empirijska primjena suprafiziolo&#x0161;kih ili supraterapijskih doza mikronutrijenata mo&#x017E;e prevenirati ili pobolj&#x0161;ati ishod infekcije COVID-19. Temeljeno na gore navedenim opservacijama, preporu&#x010D;uje se osiguravanje dnevno potrebnih koli&#x010D;ina vitamina i minerala, posebice pothranjenim bolesnicima u riziku ili oboljelim od COVID-19, s ciljem optimiranja op&#x0107;e antiinfektivne nutritivne obrane.</p>
</sec>
<sec>
<title>Preporuka 4</title>
<p>Bolesnici u karanteni ili samoizolaciji trebaju nastaviti s redovitom tjelesnom aktivno&#x0161;&#x0107;u uz primjerene mjere opreza.</p>
<p>Smanjenje rizika infekcije najbolje se posti&#x017E;e boravkom u ku&#x0107;i, &#x0161;to se preporu&#x010D;uje tijekom pandemije, posebice za osobe u riziku od COVID-19 te za sve zara&#x017E;ene s umjerenim tijekom bolesti.</p>
<p>Produ&#x017E;eni boravak u ku&#x0107;i mo&#x017E;e dovesti do poja&#x010D;anog sjedila&#x010D;kog pona&#x0161;anja poput prekomjerne koli&#x010D;ine vremena provedenog sjede&#x0107;i, le&#x017E;e&#x0107;i, i to ne samo radi odmaranja, ve&#x0107; i zbog drugih radnji poput igranja videoigara, gledanja televizije te kori&#x0161;tenja mobilnih ure&#x0111;aja. Svakodnevica nam se drasti&#x010D;no mijenja, sve se manje kre&#x0107;emo, &#x0161;to uzrokuje smanjenje dnevne energetske potro&#x0161;nje pojedinca. Posljedi&#x010D;no, karantena mo&#x017E;e dovesti do pove&#x0107;anog rizika od kroni&#x010D;nih nezaraznih bolesti, kao i potencijalnog pogor&#x0161;anja istih kod ve&#x0107; oboljelih osoba. Nadalje, javlja se velik rizik od pojave pretilosti, gubitka mi&#x0161;i&#x0107;ne mase i mi&#x0161;i&#x0107;ne snage, a postoji i mogu&#x0107;nost gubitka imunosne sposobnosti, budu&#x0107;i da je vi&#x0161;e studija ukazalo na povoljan u&#x010D;inak aerobne aktivnosti na imunosnu funkciju. U znanstvenom radu objavljenom u velja&#x010D;i ove godine, Chen i suradnici (<xref ref-type="bibr" rid="r28"><italic>28</italic></xref>) zaklju&#x010D;ili su kako bi ljudi u ovim neizvjesnim vremenima trebali biti tjelesno aktivni i kod ku&#x0107;e radi odr&#x017E;avanja funkcije imunosnog sustava i zdravlja op&#x0107;enito.</p>
<p>Izvo&#x0111;enje razli&#x010D;itih jednostavnih i lakih vje&#x017E;bi kod ku&#x0107;e i vi&#x0161;e je nego prikladno za izbjegavanje prijenosa infekcije koronavirusom i odr&#x017E;avanje zadovoljavaju&#x0107;e razine kondicije pojedinca. Takvi oblici vje&#x017E;banja mogu uklju&#x010D;ivati vje&#x017E;be snage, vje&#x017E;be ravnote&#x017E;e, vje&#x017E;be istezanja ili njihovu kombinaciju. Neki od primjera ku&#x0107;nih vje&#x017E;bi su hodanje po ku&#x0107;i, podizanje i no&#x0161;enje namirnica, naizmjeni&#x010D;ni iskoraci, penjanje po stepenicama, ustajanje sa stolca i sjedanje, &#x010D;u&#x010D;njevi uz stolac, trbu&#x0161;njaci i sklekovi. Uz to, treba uzeti u obzir i tradicionalne vje&#x017E;be poput Tai Ji Quan, Qigong i joge koje ne zahtijevaju opremu, trebaju malo prostora i mogu se vje&#x017E;bati u bilo kojem trenutku.</p>
<p>U dana&#x0161;nje doba dostupni su nam razni sadr&#x017E;aji usmjereni na poticanje tjelesne aktivnosti putem interneta, mobilnih aplikacija i televizije, a mogu biti od velike koristi. To su prikazi vje&#x017E;banja u obliku slika i videozapisa, motiviraju&#x0107;ih dnevnih i tjednih &#x201E;izazova&#x201C;, a upravo ovi alati mogu pridonijeti odr&#x017E;avanju tjelesne funkcije i mentalnog zdravlja tijekom ovoga kriti&#x010D;nog razdoblja. Uz po&#x0161;tivanje propisanih mjera, mogu se razmatrati i aktivnosti na otvorenom, poput vrtlarenja (ako posjedujete vlastiti vrt), tjelovje&#x017E;be na otvorenom (npr. badminton) ili hodanja / tr&#x010D;anja kroz &#x0161;umu (samostalno ili u manjim obiteljskim skupinama, po&#x0161;tuju&#x0107;i razmak od minimalno 2 metra). Svakodnevno &gt; 30 min ili svaki drugi dan &gt; 1h tjelovje&#x017E;be preporu&#x010D;ljivo je za odr&#x017E;avanje kondicije, mentalnog zdravlja, mi&#x0161;i&#x0107;ne mase, a time i optimalne potro&#x0161;nje energije i sastava tijela.</p>
</sec>
<sec>
<title>Preporuka 5</title>
<p>Oralni nutritivni dodaci (ONS) trebaju se koristiti kada prehrambeno savjetovanje i oboga&#x0107;ivanje hrane nisu dostatni za postizanje nutritivnih ciljeva. ONS bi trebali osigurati najmanje 400 kcal na dan uklju&#x010D;uju&#x0107;i 30 g ili vi&#x0161;e proteina na dan u razdoblju od najmanje mjesec dana. U&#x010D;inkovitost i o&#x010D;ekivana korist ONS-a procjenjuje se jednom mjese&#x010D;no.</p>
<p>Dr&#x017E;imo da se generalne smjernice o ulozi ONS-a u prevenciji i lije&#x010D;enju malnutricije mogu u potpunosti primijeniti u kontekstu COVID-19 infekcije (vidjeti i preporuke 2.1&#x2013;2.3. u ref.7 i preporuke 23,26 i 27 u ref. <xref ref-type="bibr" rid="r8">8</xref>). Osobe inficirane virusom SARS-CoV-2 koje se ne lije&#x010D;e u JIL-u treba stoga lije&#x010D;iti u svrhu prevencije ili lije&#x010D;enja malnutricije. Kad god je to mogu&#x0107;e treba preferirati oralni put unosa. Upu&#x0107;ujemo na pojedina&#x010D;ne smjernice za optimizaciju kalorijskog unosa. Nutritivno lije&#x010D;enje treba zapo&#x010D;eti rano tijekom hospitalizacije (unutar 24&#x2013;48 h). Posebnu pa&#x017E;nju treba obratiti na starije i polimorbidne bolesnike ve&#x0107; naru&#x0161;enoga nutritivnog statusa, &#x010D;ije nutritivne ciljeve treba dosizati polako da bi se izbjegao <italic>refeeding</italic> sindrom. ONS predstavlja visokoenergetsku alternativu uobi&#x010D;ajenim obrocima, a mo&#x017E;e biti dodatno oboga&#x0107;en proteinima i mikronutrijentima &#x010D;ije propisane koli&#x010D;ine treba redovito osiguravati. U slu&#x010D;ajevima upitne suradljivosti, potrebna je &#x010D;e&#x0161;&#x0107;a evaluacija i eventualno modifikacija vrste ONS-a, npr. tjedno. Nutritivnu terapiju potrebno je nastaviti i nakon otpusta iz bolnice uz individualizirani nutritivni plan i ONS, &#x0161;to je posebice va&#x017E;no ako otprije postoje rizi&#x010D;ni &#x010D;imbenici za malnutriciju koje je akutna bolest i hospitalizacija dodatno pogor&#x0161;ala.</p>
</sec>
<sec>
<title>Preporuka 6</title>
<p>U polimorbidnih hospitaliziranih bolesnika i starijih bolesnika s povoljnom prognozom &#x010D;iji se nutritivni ciljevi ne mogu posti&#x0107;i oralnim putem potrebno je zapo&#x010D;eti enteralnu prehranu (EN). Parenteralnu prehranu (PN) treba razmotriti kada EN nije indicirana ili ne mo&#x017E;e dose&#x0107;i zadane ciljeve.</p>
<p>Enteralnu prehranu treba primijeniti kada se nutritivne potrebe ne mogu zadovoljiti oralnim putem, odnosno kada se o&#x010D;ekuje da se oralni unos ne&#x0107;e mo&#x0107;i uspostaviti kroz vi&#x0161;e od tri dana ili kada se o&#x010D;ekuje da &#x0107;e zadovoljiti manje od polovice energetskih potreba tijekom vi&#x0161;e od jednog tjedna. U tom slu&#x010D;aju EN je superiorna u odnosu na PN zbog manjeg rizika infektivnih i neinfektivnih komplikacija (vidjeti preporuku 3.1. u ref. 7 i preporuku 29 u ref. <xref ref-type="bibr" rid="r8">8</xref>). Nadgledanje potencijalnih komplikacija EN ipak je potrebno redovito provoditi. U situacijama kada je realno o&#x010D;ekivati pobolj&#x0161;anje nutritivnog statusa ne postoje ograni&#x010D;enja uporabe EN ili PN &#x0161;to se ti&#x010D;e dobi ili odre&#x0111;ene dijagnoze.</p>
</sec>
</sec>
<sec sec-type="other3">
<title>Nutritivna potpora bolesnika inficiranih sa SARS-CoV-2 u jedinicama intenzivne skrbi</title>
<p>U ovom dijelu preporuke se temelje na recentnim ESPEN-ovim smjernicama o nutritivnoj terapiji u jedinicama intenzivne skrbi (<xref ref-type="bibr" rid="r6"><italic>6</italic></xref>) i stupnjevima respiratorne terapije u ovisnosti o stanju bolesnika (<xref ref-type="bibr" rid="r4"><italic>4</italic></xref>). Nutritivna problematika treba uzeti u obzir vrstu respiratorne potpore u jedinicama intenzivne skrbi (<xref ref-type="table" rid="t2">Table 2</xref>).</p>
<table-wrap id="t2" position="float">
<label>Table 2</label><caption><title>Nutritivna potpora u ovisnosti o respiratornoj potpori bolesnika u JIL-u.</title>
</caption>
<table frame="hsides" rules="groups">
<col width="19.54%"/>
<col width="20.11%"/>
<col width="21.3%"/>
<col width="18.94%"/>
<col width="20.11%"/>
<thead>
<tr>
<th valign="middle" align="left" scope="col" style="border-left: solid 0.75pt; border-top: solid 0.75pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt"></th>
<th valign="middle" align="left" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.75pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt">Odjel</th>
<th valign="middle" align="left" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.75pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt">JIL<break/>dan 1&#x2013;2</th>
<th valign="middle" align="left" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.75pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt">JIL<break/>dan 2&#x2013;</th>
<th valign="middle" align="left" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.75pt; border-right: solid 0.75pt; border-bottom: solid 0.50pt">Odjel rehabilitacija</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row">Oksigenoterapija i mehani&#x010D;ka ventilacija</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt">Nije potrebna ili O2 potpora putem (H)FNC</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt">FNC pa mehani&#x010D;ka ventilacija</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt">Mehani&#x010D;ka ventilacija</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.75pt; border-bottom: solid 0.50pt">Mogu&#x0107;a ekstubacija i transfer na odjel</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row">Zatajenje organa</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt">Bilateralna pneumonija, trombocitopenija</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt">Pogor&#x0161;anje respiratornog statusa; ARDS; mogu&#x0107;i &#x0161;ok</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt">Mogu&#x0107;i MOF</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.75pt; border-bottom: solid 0.50pt">Progresivni oporavak nakon ekstubacije</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.75pt" scope="row">Nutritivna potpora</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.75pt">Probir malnutricije; oralno hranjenje/ONS, EN ili PN ako je potrebno</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.75pt">Definirati energetske i proteinske ciljeve;<break/>u slu&#x010D;aju FNC ili NIV davati hranu oralno ili EN, a ako nije mogu&#x0107;e, PN</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.75pt">Rano enteralno hranjenje, proteini, mobilizacija</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.75pt; border-bottom: solid 0.75pt">Procjena disfagije; oralna prehrana ako je mogu&#x0107;e; ako nije EN ili PN;<break/>povisiti unos proteina i dodati vje&#x017E;banje</td>
</tr>
</tbody>
</table><table-wrap-foot>
<p>Prema razvoju progresije infekcije, predla&#x017E;e se medicinska nutritivna terapija zajedno s respiratornom potporom u JIL-u. Kratice: JIL, jedinica intenzivne skrbi; FNC, proto&#x010D;na nosna kanila; (H) FNC = (High) FNC, nosna kanila visokog protoka; ARDS, akutni respiratorni distres sindrom; MOF, multiorgansko zatajenje; ONS, oralna nutritivna potpora.</p>
</table-wrap-foot></table-wrap>
<sec>
<title>Stanje prije intubacije</title>
<sec>
<title>Preporuka 7</title>
<p>Za COVID-19 bolesnike u jedinicama intenzivnog lije&#x010D;enja koji nisu na mehani&#x010D;koj ventilaciji i koji ne dosi&#x017E;u energetske ciljeve uobi&#x010D;ajenom prehranom, prvo treba razmotriti oralne nutritivne dodatke (ONS), a potom enteralnu prehranu. Ako postoje prepreke enteralnom putu, preporu&#x010D;uje se periferna parenteralna prehrana.</p>
<p>Neinvazivna mehani&#x010D;ka ventilacija (NIV): Op&#x0107;enito, samo malom dijelu bolesnika (25&#x2013;45%) koji su primljeni u JIL radi monitoriranja, neinvazivne ventilacije i opservacije nakon ekstubacije bude propisana oralna prehrana, kao &#x0161;to je prikazano u istra&#x017E;ivanju <italic>Nutrition Day ICU</italic> (<xref ref-type="bibr" rid="r29"><italic>29</italic></xref>). Reeves, et al. (<xref ref-type="bibr" rid="r30"><italic>30</italic></xref>) u svom su istra&#x017E;ivanju zaklju&#x010D;ili da energetsko-proteinski unos u bolesnika s ARDS-om lije&#x010D;enih NIV-om nije adekvatan. Treba istaknuti da komplikacije di&#x0161;nog puta mogu nastati nakon duljeg medijana neinvazivne ventilacije kod bolesnika koji su dobivali EN (<xref ref-type="bibr" rid="r31"><italic>31</italic></xref>). Na preporuku za zapo&#x010D;injanje EN utje&#x010D;e &#x010D;injenica da postavljanje nazogastri&#x010D;ne sonde (NGS) radi hranjenja mo&#x017E;e rezultirati: 1) propu&#x0161;tanjem zraka, &#x0161;to mo&#x017E;e kompromitirati u&#x010D;inkovitost NIV-a; 2) distenzijom &#x017E;eluca koja mo&#x017E;e utjecati na funkciju o&#x0161;ita i u&#x010D;inkovitost NIV-a (<xref ref-type="bibr" rid="r32"><italic>32</italic></xref>). Ove zapa&#x017E;ene pojave mogu biti barem dijelom razlog neprimjerene primjene enteralne prehrane, &#x0161;to pak rezultira gladovanjem bolesnika, posebice tijekom prvih 48 sati u JIL-u, i ve&#x0107;im rizikom pothranjenosti i komplikacija (<xref ref-type="bibr" rid="r33"><italic>33</italic></xref>). Periferna PN mo&#x017E;e se stoga primijeniti u tim situacijama.</p>
<p>Nosne kanile (FNC) i nosne kanile visokog protoka (HFNC): &#x010C;esto se smatra da bolesnici lije&#x010D;eni oksigenoterapijom putem nosnih kanila mogu nastaviti oralnu prehranu (<xref ref-type="bibr" rid="r34"><italic>34</italic></xref>). Nekoliko istra&#x017E;ivanja opisalo je implementaciju nutritivne potpore tijekom kori&#x0161;tenja ove tehnike. Ipak, ograni&#x010D;eni dokazi ukazuju da je energetsko-proteinski unos nedovoljan da bi se sprije&#x010D;ila ili lije&#x010D;ila pothranjenost bolesnika s nosnim kanilama visokog protoka (<xref ref-type="bibr" rid="r35"><italic>35</italic></xref>). Preporu&#x010D;uje se primjerena procjena unosa nutrijenata za vrijeme uzimanja ONS-a ili EN ako oralni put nije dostatan.</p>
</sec>
</sec>
<sec>
<title>Razdoblje mehani&#x010D;ke ventilacije</title>
<p>Ako se nakon dva sata terapije nosnom kanilom visokog protoka ili neinvazivnom ventilacijom ne postigne zadovoljavaju&#x0107;a oksigenacija, postavlja se indikacija za mehani&#x010D;ku ventilaciju. U ovoj situaciji primjenjive su ESPEN-ove smjernice za prehranu u jedinicama intenzivne skrbi (<xref ref-type="bibr" rid="r6"><italic>6</italic></xref>) prema kojima smo ovdje sa&#x017E;eli preporuke za intubirane i mehani&#x010D;ki ventilirane COVID-19 bolesnike.</p>
<sec>
<title>Preporuka 8</title>
<p>Intubiranim i mehani&#x010D;ki ventiliranim COVID-19 bolesnicima enteralnu prehranu (EN) treba zapo&#x010D;eti pomo&#x0107;u nazogastri&#x010D;ne sonde (NGS); postpilori&#x010D;no hranjenje rezervirano je za bolesnike sa &#x017E;elu&#x010D;anom intolerancijom nakon terapije prokineticima ili za bolesnike s visokim rizikom od aspiracije. Le&#x017E;e&#x0107;i polo&#x017E;aj ne predstavlja ograni&#x010D;enje ili kontraindikaciju za EN.</p>
<p>Energetske potrebe: kako bi se ustanovile energetske potrebe potrebno je odrediti potro&#x0161;nju energije bolesnika (EE), idealno pomo&#x0107;u indirektne kalorimetrije. Izokalorijska, prije nego hipokalorijska prehrana propisuje se potom nakon rane faze akutne bolesti. Ako kalorimetrija nije dostupna, bolji uvid u EE nego jednad&#x017E;be dat &#x0107;e VO2 (potro&#x0161;nja kisika) iz katetera u plu&#x0107;noj arteriji ili VCO2 (proizvodnja uglji&#x010D;nog dioksida) iz respiratora.</p>
<p>Opskrba energije: u ranoj fazi akutne bolesti primjenjuje se hipokalorijska prehrana (koja ne prelazi 70% EE) s postupnim pove&#x0107;anjem koli&#x010D;ine do 80&#x2013;100% nakon tre&#x0107;ega dana. Ako se koriste jednad&#x017E;be za izra&#x010D;un EE, tijekom prvog tjedna boravka u JIL-u preporu&#x010D;uje se hipokalorijska prehrana (ispod 70% predvi&#x0111;enih potreba) kako bi se izbjeglo prekomjerno hranjenje (<italic>overfeeding</italic>).</p>
<p>Proteinske potrebe: tijekom kriti&#x010D;ne bolesti postupno se unose koli&#x010D;ine proteina od 1,3 g/kg TM/dan. Dokazano je da ova ciljna vrijednost pobolj&#x0161;ava pre&#x017E;ivljenje, dominantno u krhkih bolesnika. Za pretile bolesnike u situacijama kad nije dostupno mjerenje sastava tijela preporu&#x010D;uje se 1,3 g/kg &#x201E;prilago&#x0111;ene TM&#x201C;/dan proteina. Prilago&#x0111;ena tjelesna masa izra&#x010D;unava se kao idealna TM + (aktualna TM &#x2013; idealna TM) x 0,33 (<xref ref-type="bibr" rid="r6"><italic>6</italic></xref>). S obzirom na va&#x017E;nost o&#x010D;uvanja skeletne mi&#x0161;i&#x0107;ne mase i funkcije i izrazito kataboli&#x010D;ko stanje bolesti i boravka u JIL-u, mogu se upotrijebiti dodatne strategije u svrhu poja&#x010D;anja mi&#x0161;i&#x0107;nog anabolizma. Posebice treba spomenuti kontroliranu tjelesnu aktivnost i mobilizaciju koje doprinose blagodatima nutritivne terapije.</p>
</sec>
<sec>
<title>Preporuka 9</title>
<p>Kod bolesnika koji ne toleriraju ciljnu koli&#x010D;inu enteralne prehrane (EN) tijekom prvog tjedna u JIL-u treba razmotriti zapo&#x010D;injanje parenetralne prehrane (PN) na individualnoj osnovi. PN ne treba zapo&#x010D;injati dok se nisu iscrpile sve strategije za maksimalnu toleranciju EN.</p>
<p>Ograni&#x010D;enja i mjere opreza: u bolesnika na mehani&#x010D;koj ventilaciji dosizanje punog opsega nutritivne potpore treba provoditi postupno.</p>
<p>Kontraindikacije</p>
<p>EN treba odgoditi:</p>
<list id="L4" list-type="simple"><list-item><p>u situacijama hemodinamske nestabilnosti i &#x0161;oka;</p></list-item>
<list-item><p>u situacijama nekontrolirane &#x017E;ivotno ugro&#x017E;avaju&#x0107;e hipoksemije, hiperkapnije ili acidoze.</p></list-item></list>
<p>Mjere opreza tijekom razdoblja rane stabilizacije: zapo&#x010D;eti s malom koli&#x010D;inom EN:</p>
<list id="L5" list-type="simple"><list-item><p>&#x010D;im je stanje &#x0161;oka kontrolirano teku&#x0107;inom, vazopresorima ili inotropima, no treba paziti na znakove ishemije crijeva;</p></list-item>
<list-item><p>u bolesnika sa stabilnom hipoksemijom i kompenziranom ili permisivnom hiperkapnijom i acidozom.</p></list-item></list>
<p>Op&#x0107;i komentari: kada je bolesnik stabiliziran, &#x010D;ak i u le&#x017E;e&#x0107;em polo&#x017E;aju, mogu&#x0107;e je zapo&#x010D;eti EN u koli&#x010D;ini do 30% energetskih potreba izmjerenih indirektnom kalorimetrijom. Koli&#x010D;ina EN se pove&#x0107;ava progresivno. Ako se koriste jednad&#x017E;be, preporu&#x010D;uje se zapo&#x010D;injanje s 20 kcal/kg TM/dan uz pove&#x0107;anje energetskog unosa do 50&#x2013;70% ciljnih vrijednosti drugoga dana da bi se dostiglo 80&#x2013;100% &#x010D;etvrtoga dana. Ciljnu vrijednost unosa proteina od 1,3 g/kg TM/dan treba dosti&#x0107;i od tre&#x0107;ega do petoga dana. NGS je preferirani put unosa EN, ali u slu&#x010D;ajevima velikog rezidualnoga &#x017E;elu&#x010D;anog volumena (vi&#x0161;e od 500 mL) potrebno je &#x0161;to prije postaviti nazojejunalnu sondu (NJS). Iako za to nema &#x010D;vrstih dokaza, smatra se da uporaba omega-3 masnih kiselina mo&#x017E;e pobolj&#x0161;ati oksigenaciju. U slu&#x010D;aju intolerancije na EN, treba razmotriti PN. Vrijednosti glikemije treba odr&#x017E;avati unutar referentnih vrijednosti izme&#x0111;u 6 i 8 mmol/L, uz kontrolu triglicerida i elektrolita, uklju&#x010D;uju&#x0107;i fosfate, kalij i magnezij (<xref ref-type="bibr" rid="r6"><italic>6</italic></xref>).</p>
</sec>
</sec>
<sec>
<title>Razdoblje nakon mehani&#x010D;ke ventilacije i disfagija</title>
<p>U razdoblju nakon mehani&#x010D;ke ventilacije bolesnici &#x010D;esto imaju problema s gutanjem i posljedi&#x010D;nom disfagijom, &#x0161;to mo&#x017E;e zna&#x010D;ajno ograni&#x010D;avati oralni unos, &#x010D;ak i ako je op&#x0107;e stanje zna&#x010D;ajno pobolj&#x0161;ano. Sljede&#x0107;e preporuke mogu se stoga primijeniti na COVID-19 bolesnike nakon ekstubacije.</p>
<sec>
<title>Preporuka 10</title>
<p>Kod bolesnika u JIL-u s disfagijom nakon ekstubacije treba razmotriti hranu prilago&#x0111;ene teksture. Ako je o&#x0161;te&#x0107;en akt gutanja, indicirana je EN. U stanjima vrlo visokog rizika od aspiracije indicirano je postavljanje NJS, ili, ako to nije mogu&#x0107;e, va&#x0111;enje sonde i privremena PN tijekom razdoblja vje&#x017E;banja gutanja.</p>
<p>Poreme&#x0107;aji gutanja u postekstubacijskom periodu mogu trajati i do 21 dan, posebice u starijih bolesnika i nakon prolongirane intubacije (<xref ref-type="bibr" rid="r36"><italic>36</italic></xref>, <xref ref-type="bibr" rid="r37"><italic>37</italic></xref>), &#x0161;to ovu komplikaciju &#x010D;ini relevantnom u COVID-19 bolesnika. Opisano je da je &#x010D;ak do 24% starijih bolesnika ovisno o prehrani pomo&#x0107;u sonde tri tjedna nakon ekstubacije (<xref ref-type="bibr" rid="r38"><italic>38</italic></xref>). Te&#x0161;ka postekstubacijska disfagija povezuje se s lo&#x0161;ijim ishodima uklju&#x010D;uju&#x0107;i pneumonije, reintubacije i smrtnost tijekom hospitalizacije. Recentna istra&#x017E;ivanja pokazuju da 29% bolesnika u JIL-u ima protrahirani postekstubacijski poreme&#x0107;aj gutanja pri otpustu, a neke pote&#x0161;ko&#x0107;e s gutanjem zaostaju &#x010D;ak i &#x010D;etiri mjeseca nakon otpusta (<xref ref-type="bibr" rid="r39"><italic>39</italic></xref>). Autori preporu&#x010D;uju da se takvi bolesnici upute na procjenu akta gutanja kako bi se izbjegle komplikacije vezane za oralno hranjenje (<xref ref-type="bibr" rid="r40"><italic>40</italic></xref>, <xref ref-type="bibr" rid="r41"><italic>41</italic></xref>). Nakon traheotomije ve&#x0107;ina bolesnika se mo&#x017E;e vratiti na uobi&#x010D;ajeni oralni unos hrane, iako dugotrajna trahealna kanila mo&#x017E;e odgoditi po&#x010D;etak zadovoljavaju&#x0107;ega oralnog unosa (<xref ref-type="bibr" rid="r42"><italic>42</italic></xref>). Ne postoje zna&#x010D;ajna istra&#x017E;ivanja o dodatnoj PN u ovoj populaciji, iako se ona mo&#x017E;e primijeniti ako se energetsko-proteinski ciljevi ne mogu dose&#x0107;i na drugi na&#x010D;in.</p>
</sec>
</sec>
</sec>
<sec sec-type="other4">
<title>Ste&#x010D;ena slabost nakon JIL-a (<italic>ICU-acquired weakness ICUAW</italic>)</title>
<p>Dugotrajna prognoza bolesnika koji su pre&#x017E;ivjeli hospitalizaciju u JIL-u ovisi o zaostalim fizi&#x010D;kim, kognitivnim i mentalnim o&#x0161;te&#x0107;enjima (<xref ref-type="bibr" rid="r43"><italic>43</italic></xref>). Gubitak mi&#x0161;i&#x0107;ne mase i funkcije mo&#x017E;e biti nevjerojatan, &#x0161;to je i najve&#x0107;i problem pre&#x017E;ivjelih (<xref ref-type="bibr" rid="r44"><italic>44</italic></xref>). To se posebice odnosi na starije i komorbidne bolesnike kod kojih &#x010D;e&#x0161;&#x0107;e vi&#x0111;amo preegzistiraju&#x0107;a kataboli&#x010D;ka stanja i o&#x0161;te&#x0107;enje mi&#x0161;i&#x0107;ne mase i funkcije, a ova skupina bolesnika je sama po sebi sklonija izrazitijem kataboli&#x010D;kom odgovoru na COVID-19 i boravku u JIL-u. Za ve&#x0107;inu COVID-19 bolesnika trajanje hospitalizacije u JIL-u du&#x017E;e od dva tjedna dodatno pogor&#x0161;ava mi&#x0161;i&#x0107;no-kataboli&#x010D;ko stanje. Primjeren unos energije, pritom vode&#x0107;i ra&#x010D;una o izbjegavanju prekomjernog hranjenja (<italic>overfeeding</italic>), i primjeren unos proteina od presudne su va&#x017E;nosti u prevenciji te&#x0161;koga gubitka mi&#x0161;i&#x0107;ne mase i funkcije (vidjeti Preporuku 2 i komentare). Kako nema kvalitetnih istra&#x017E;ivanja o nekim dodatnim specifi&#x010D;nim terapijama na ovom podru&#x010D;ju, kona&#x010D;ne preporuke se ne mogu donijeti, me&#x0111;utim recentna istra&#x017E;ivanja pokazuju da postoji pozitivan u&#x010D;inak tjelesne aktivnosti u kombinaciji s dodatnim aminokiselinama ili njihovim metabolitima (<xref ref-type="bibr" rid="r45"><italic>45</italic></xref>, <xref ref-type="bibr" rid="r46"><italic>46</italic></xref>).</p>
</sec>
<sec sec-type="other5">
<title>Zavr&#x0161;ne primjedbe</title>
<p>Nutritivna intervencija i terapija trebaju biti integralni dio skrbi za oboljele od SARS-CoV-2 infekcije u jedinicama intenzivnog lije&#x010D;enja, odjelima interne medicine, kao i u op&#x0107;oj praksi. U ovom dokumentu predlo&#x017E;eno je deset preporuka koje se odnose na nutritivnu skrb COVID-19 bolesnika (<xref ref-type="fig" rid="f1">Figure 1</xref>). Nutritivna terapija treba biti dijelom skrbi za ove bolesnike tijekom svih koraka lije&#x010D;enja, a posebnu pa&#x017E;nju treba posvetiti starijim, krhkim i komorbidnim bolesnicima. Smatramo da se pridr&#x017E;avanjem ovih preporuka ishod bolesnika mo&#x017E;e pobolj&#x0161;ati, a oporavak skratiti, pogotovo nakon perioda boravka u JIL-u. Samo sveobuhvatan pristup koji ne&#x0107;e izostaviti prehranu iz mjera za odr&#x017E;avanja &#x017E;ivota ima mogu&#x0107;nost pobolj&#x0161;ati ishod, posebice u fazi oporavka.</p>
<fig id="f1" position="float" fig-type="figure"><label>Figure 1</label><caption><p>Nutritivna skrb osoba u riziku od COVID-19, osoba oboljelih od COVID-19 i bolesnika u JIL-u na mehani&#x010D;koj ventilaciji. Za detalje vidjeti tekst.</p></caption><graphic xlink:href="LV-142-75-f1"></graphic></fig>
<p>Dok su zdravstveni djelatnici zaokupljeni osobnom za&#x0161;titnom opremom (PPE, <italic>personal protecting equipment</italic>), na&#x010D;inom njene uporabe ili pove&#x0107;anjem broja respiratora, istovremeno je va&#x017E;na i edukacija o prehrani ovih bolesnika. Predla&#x017E;emo da sudionici ovog procesa poput SZO-a, ministarstava zdravstva, nutricionista, stru&#x010D;njaka iz podru&#x010D;ja javnog zdravstva razvijaju mehanizme diseminacije znanja me&#x0111;u zdravstvenim djelatnicima. Uprava bolnice trebala bi nutritivne potrebe dr&#x017E;ati klju&#x010D;nima u procesu raspodjele resursa. Kod pothranjenih bolesnika ve&#x0107;a je vjerojatnost da dolaze iz lo&#x0161;ijega socioekonomskog okru&#x017E;ja i rje&#x0161;avanje malnutricije va&#x017E;an je korak u tome da ne izostavimo nikoga u ovoj borbi protiv COVID-19 pandemije.</p>
</sec>
</body>
<back>
<ack>
<p>Prijevod smjernica na hrvatski jezik omogu&#x0107;ilo je Hrvatsko dru&#x0161;tvo za klini&#x010D;ku prehranu Hrvatskoga lije&#x010D;ni&#x010D;kog zbora.</p>
<p>Prevele: prof. dr. sc. Darija Vrane&#x0161;i&#x0107; Bender i doc. dr. sc. Tajana Pavi&#x0107;</p>
<p>* Ovaj se &#x010D;lanak mo&#x017E;e citirati i u originalu:</p>
<p>Barazzoni R et al., ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clini Nutrition, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.clnu.2020.03.022">https://doi.org/10.1016/j.clnu.2020.03.022</ext-link></p>
</ack>
<fn-group>
<fn fn-type="conflict">
<label>Sukob interesa</label>
<p>Autori izjavljuju da nemaju sukoba interesa &#x0161;to se ti&#x010D;e sadr&#x017E;aja ovog rada. Sami autori su odgovorni za stavove iznesene u ovome radu, a oni nu&#x017E;no ne predstavljaju poglede, odluke ili pravila Svjetske zdravstvene organizacije.</p>
</fn>
</fn-group>
<ref-list>
<title>LITERATURA</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><etal/></person-group> <article-title>A novel coronavirus from patients with pneumonia in China, 2019.</article-title> <source>N Engl J Med</source>. <year>2020</year>;<volume>382</volume>:<fpage>727</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa2001017</pub-id><pub-id pub-id-type="pmid">31978945</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>N</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><etal/></person-group> <article-title>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.</article-title> <source>Lancet</source>. <year>2020</year>;<volume>395</volume>:<fpage>507</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30211-7</pub-id><pub-id pub-id-type="pmid">32007143</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><etal/></person-group> <article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.</article-title> <source>Lancet</source>. <year>2020</year>;<volume>395</volume>:<fpage>497</fpage>&#x2013;<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30183-5</pub-id><pub-id pub-id-type="pmid">31986264</pub-id></mixed-citation></ref>
<ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouadma</surname><given-names>L</given-names></name><name><surname>Lescure</surname><given-names>FX</given-names></name><name><surname>Lucet</surname><given-names>JC</given-names></name><name><surname>Yazdanpanah</surname><given-names>Y</given-names></name><name><surname>Timsit</surname><given-names>JF</given-names></name></person-group>. <article-title>Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists.</article-title> <source>Intensive Care Med</source>. <year>2020</year> February 26;<volume>&#x2022;&#x2022;&#x2022;</volume>:  <comment>[Epub ahead of print]</comment><pub-id pub-id-type="doi">10.1007/s00134-020-05967-x</pub-id><pub-id pub-id-type="pmid">32103284</pub-id></mixed-citation></ref>
<ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Yu</surname><given-names>T</given-names></name><name><surname>Du</surname><given-names>R</given-names></name><etal/></person-group> <article-title>Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.</article-title> <source>Lancet</source>. <year>2020</year> March 11;<volume>&#x2022;&#x2022;&#x2022;</volume>:  <comment>[Epub ahead of print]</comment><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30566-3</pub-id><pub-id pub-id-type="pmid">32171076</pub-id></mixed-citation></ref>
<ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>P</given-names></name><name><surname>Blaser</surname><given-names>AR</given-names></name><name><surname>Berger</surname><given-names>MM</given-names></name><etal/></person-group> <article-title>ESPEN guideline on clinical nutrition in the intensive care unit.</article-title> <source>Clin Nutr</source>. <year>2019</year>;<volume>38</volume>:<fpage>48</fpage>&#x2013;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1016/j.clnu.2018.08.037</pub-id><pub-id pub-id-type="pmid">30348463</pub-id></mixed-citation></ref>
<ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>F</given-names></name><name><surname>Schuetz</surname><given-names>P</given-names></name><name><surname>Bounoure</surname><given-names>L</given-names></name><etal/></person-group> <article-title>ESPEN guideline on nutritional support for polymorbid internal medicine patients.</article-title> <source>Clin Nutr</source>. <year>2018</year>;<volume>37</volume>:<fpage>336</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.clnu.2017.06.025</pub-id><pub-id pub-id-type="pmid">28802519</pub-id></mixed-citation></ref>
<ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkert</surname><given-names>D</given-names></name><name><surname>Beck</surname><given-names>AM</given-names></name><name><surname>Cederholm</surname><given-names>T</given-names></name><etal/></person-group> <article-title>ESPEN guideline on clinical nutrition and hydration in geriatrics.</article-title> <source>Clin Nutr</source>. <year>2019</year>;<volume>38</volume>:<fpage>10</fpage>&#x2013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1016/j.clnu.2018.05.024</pub-id><pub-id pub-id-type="pmid">30005900</pub-id></mixed-citation></ref>
<ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cederholm</surname><given-names>T</given-names></name><name><surname>Barazzoni</surname><given-names>R</given-names></name><name><surname>Austin</surname><given-names>P</given-names></name><etal/></person-group> <article-title>ESPEN guidelines on definitions and terminology of clinical nutrition.</article-title> <source>Clin Nutr</source>. <year>2017</year>;<volume>36</volume>:<fpage>49</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.clnu.2016.09.004</pub-id><pub-id pub-id-type="pmid">27642056</pub-id></mixed-citation></ref>
<ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cederholm</surname><given-names>T</given-names></name><name><surname>Jensen</surname><given-names>GL</given-names></name><name><surname>Correia</surname><given-names>MITD</given-names></name><etal/><collab>GLIM Core Leadership Committee</collab></person-group>. <article-title><italic>GLIM Working Group</italic>. GLIM criteria for the diagnosis of malnutrition &#x2013; a consensus report from the global clinical nutrition community.</article-title> <source>Clin Nutr</source>. <year>2019</year>;<volume>38</volume>:<fpage>1</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.clnu.2018.08.002</pub-id><pub-id pub-id-type="pmid">30181091</pub-id></mixed-citation></ref>
<ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Short</surname><given-names>KR</given-names></name><name><surname>Kedzierska</surname><given-names>K</given-names></name><name><surname>van de Sandt</surname><given-names>CE</given-names></name></person-group>. <article-title>Back to the future: lessons learned from the 1918 influenza pandemic.</article-title> <source>Front Cell Infect Microbiol</source>. <year>2018</year> October 8;<volume>8</volume>:<fpage>343</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2018.00343</pub-id><pub-id pub-id-type="pmid">30349811</pub-id></mixed-citation></ref>
<ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reyes</surname><given-names>L</given-names></name><name><surname>Arvelo</surname><given-names>W</given-names></name><name><surname>Estevez</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Population-based surveillance for 2009 pandemic influenza A (H1N1) virus in Guatemala, 2009.</article-title> <source>Influenza Other Respir Viruses</source>. <year>2010</year>;<volume>4</volume>:<fpage>129</fpage>&#x2013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1111/j.1750-2659.2010.00138.x</pub-id><pub-id pub-id-type="pmid">20409209</pub-id></mixed-citation></ref>
<ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maruyama</surname><given-names>T</given-names></name><name><surname>Fujisawa</surname><given-names>T</given-names></name><name><surname>Suga</surname><given-names>S</given-names></name><etal/></person-group> <article-title>Outcomes and prognostic features of patients with influenza requiring hospitalization and receiving early antiviral therapy: a prospective multicenter cohort study.</article-title> <source>Chest</source>. <year>2016</year>;<volume>149</volume>:<fpage>526</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1378/chest.14-2768</pub-id><pub-id pub-id-type="pmid">26203671</pub-id></mixed-citation></ref>
<ref id="r14"><label>14</label><mixed-citation publication-type="web">World Health Organization. Regional Office for Europe, data and statistics on obesity. Dostupno na: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.euro.who.int/en/healthtopics/noncommunicable-diseases/obesity/data-and-statistics">http://www.euro.who.int/en/healthtopics/noncommunicable-diseases/obesity/data-and-statistics</ext-link>. Pristupljeno: 23. 3. 2020.</mixed-citation></ref>
<ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name></person-group>. <article-title>Potential interventions for novel coronavirus in China: a systematic review.</article-title> <source>J Med Virol</source>. <year>2020</year>;<volume>92</volume>:<fpage>479</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.25707</pub-id><pub-id pub-id-type="pmid">32052466</pub-id></mixed-citation></ref>
<ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papadimitriou-Olivgeris</surname><given-names>M</given-names></name><name><surname>Gkikopoulos</surname><given-names>N</given-names></name><name><surname>W&#x00FC;st</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Predictors of mortality of influenza virus infections in a Swiss Hospital during four influenza seasons: role of quick sequential organ failure assessment.</article-title> <source>Eur J Intern Med</source>. <year>2019</year>;<volume>31</volume>(<issue>19</issue>):<fpage>30460</fpage>&#x2013;<lpage>1</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejim.2019.12.022</pub-id><pub-id pub-id-type="pmid">31899057</pub-id></mixed-citation></ref>
<ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cannell</surname><given-names>JJ</given-names></name><name><surname>Vieth</surname><given-names>R</given-names></name><name><surname>Umhau</surname><given-names>JC</given-names></name><etal/></person-group> <article-title>Epidemic influenza and vitamin D.</article-title> <source>Epidemiol Infect</source>. <year>2006</year>;<volume>134</volume>:<fpage>1129</fpage>&#x2013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1017/S0950268806007175</pub-id><pub-id pub-id-type="pmid">16959053</pub-id></mixed-citation></ref>
<ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mascitelli</surname><given-names>L</given-names></name><name><surname>Grant</surname><given-names>WB</given-names></name><name><surname>Goldstein</surname><given-names>MR</given-names></name></person-group>. <article-title>Obesity, influenza virus infection, and hypovitaminosis D.</article-title> <source>J Infect Dis</source>. <year>2012</year>;<volume>206</volume>:<fpage>1481</fpage>&#x2013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jis520</pub-id><pub-id pub-id-type="pmid">22927457</pub-id></mixed-citation></ref>
<ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goncalves-Mendes</surname><given-names>N</given-names></name><name><surname>Talvas</surname><given-names>J</given-names></name><name><surname>Dual&#x00E9;</surname><given-names>C</given-names></name><etal/></person-group> <article-title>Impact of vitamin D supplementation on influenza vaccine response and immune functions in deficient elderly persons: a randomized placebo-controlled trial.</article-title> <source>Front Immunol</source>. <year>2019</year>;<volume>10</volume>:<fpage>65</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.00065</pub-id><pub-id pub-id-type="pmid">30800121</pub-id></mixed-citation></ref>
<ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preidis</surname><given-names>GA</given-names></name><name><surname>McCollum</surname><given-names>ED</given-names></name><name><surname>Mwansambo</surname><given-names>C</given-names></name><name><surname>Kazembe</surname><given-names>PN</given-names></name><name><surname>Schutze</surname><given-names>GE</given-names></name><name><surname>Kline</surname><given-names>MW</given-names></name></person-group>. <article-title>Pneumonia and malnutrition are highly predictive of mortality among African children hospitalized with human immunodeficiency virus infection or exposure in the era of antiretroviral therapy.</article-title> <source>J Pediatr</source>. <year>2011</year>;<volume>159</volume>:<fpage>484</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2011.02.033</pub-id><pub-id pub-id-type="pmid">21489553</pub-id></mixed-citation></ref>
<ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villar</surname><given-names>LM</given-names></name><name><surname>Del Campo</surname><given-names>JA</given-names></name><name><surname>Ranchal</surname><given-names>I</given-names></name><name><surname>Lampe</surname><given-names>E</given-names></name><name><surname>Romero-Gomez</surname><given-names>M</given-names></name></person-group>. <article-title>Association between vitamin D and hepatitis C virus infection: a meta-analysis.</article-title> <source>World J Gastroenterol</source>. <year>2013</year>;<volume>19</volume>:<fpage>5917</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v19.i35.5917</pub-id><pub-id pub-id-type="pmid">24124339</pub-id></mixed-citation></ref>
<ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nanri</surname><given-names>A</given-names></name><name><surname>Nakamoto</surname><given-names>K</given-names></name><name><surname>Sakamoto</surname><given-names>N</given-names></name><etal/></person-group> <article-title>Association of serum 25-hydroxyvitamin D with influenza in case-control study nested in a cohort of Japanese employees.</article-title> <source>Clin Nutr</source>. <year>2017</year>;<volume>36</volume>:<fpage>1288</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.clnu.2016.08.016</pub-id><pub-id pub-id-type="pmid">27595379</pub-id></mixed-citation></ref>
<ref id="r23"><label>23</label><mixed-citation publication-type="other">Lee MD, Lin CH, Lei WT, et al. Does vitamin D deficiency affect the immunogenic responses to influenza vaccination? A systematic review and meta-analysis. Nutrients 2018;10:409. Dostupno na: https://doi:<pub-id pub-id-type="doi">10.3390/nu10040409</pub-id></mixed-citation></ref>
<ref id="r24"><label>24</label><mixed-citation publication-type="other">Nonnecke BJ, McGill JL, Ridpath JF, Sacco RE, Lippolis JD, Reinhardt TA. Acute phase response elicited by experimental bovine diarrhea virus (BVDV) infection is associated with decreased vitamin D and E status of vitamin-replete preruminant calves. J Dairy Sci 2014;97:5566&#x2013;79. Dostupno na: https://doi.org/<pub-id pub-id-type="doi">10.3168/jds.2014-8293</pub-id></mixed-citation></ref>
<ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>West</surname><given-names>CE</given-names></name><name><surname>Sijtsma</surname><given-names>SR</given-names></name><name><surname>Kouwenhoven</surname><given-names>B</given-names></name><name><surname>Rombout</surname><given-names>JH</given-names></name><name><surname>van der Zijpp</surname><given-names>AJ</given-names></name></person-group>. <article-title>Epithelia-damaging virus infections affect vitamin A status in chickens.</article-title> <source>J Nutr</source>. <year>1992</year>;<volume>122</volume>:<fpage>333</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/jn/122.2.333</pub-id><pub-id pub-id-type="pmid">1310111</pub-id></mixed-citation></ref>
<ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somarriba</surname><given-names>G</given-names></name><name><surname>Neri</surname><given-names>D</given-names></name><name><surname>Schaefer</surname><given-names>N</given-names></name><name><surname>Miller</surname><given-names>TL</given-names></name></person-group>. <article-title>The effect of aging, nutrition, and exercise during HIV infection.</article-title> <source>HIV AIDS (Auckl)</source>. <year>2010</year>;<volume>2</volume>:<fpage>191</fpage>&#x2013;<lpage>201</lpage>.<pub-id pub-id-type="pmid">22096398</pub-id></mixed-citation></ref>
<ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semba</surname><given-names>RD</given-names></name><name><surname>Tang</surname><given-names>AM</given-names></name></person-group>. <article-title>Micronutrients and the pathogenesis of human immunodeficiency virus infection.</article-title> <source>Br J Nutr</source>. <year>1999</year>;<volume>81</volume>:<fpage>181</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1017/S0007114599000379</pub-id><pub-id pub-id-type="pmid">10434844</pub-id></mixed-citation></ref>
<ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Mao</surname><given-names>L</given-names></name><name><surname>Nassis</surname><given-names>GP</given-names></name><name><surname>Harmer</surname><given-names>P</given-names></name><name><surname>Ainsworth</surname><given-names>BE</given-names></name><name><surname>Li</surname><given-names>F</given-names></name></person-group>. <article-title>Wuhan coronavirus (2019-nCoV): The need to maintain regular physical activity while taking precautions.</article-title> <source>J Sport Health Sci</source>. <year>2020</year>;<volume>9</volume>:<fpage>103</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.jshs.2020.02.001</pub-id><pub-id pub-id-type="pmid">32099716</pub-id></mixed-citation></ref>
<ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bendavid</surname><given-names>I</given-names></name><name><surname>Singer</surname><given-names>P</given-names></name><name><surname>Theilla</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Nutrition Day ICU: A 7 year worldwide prevalence study of nutrition practice in intensive care.</article-title> <source>Clin Nutr</source>. <year>2017</year>;<volume>36</volume>:<fpage>1122</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.clnu.2016.07.012</pub-id><pub-id pub-id-type="pmid">27637833</pub-id></mixed-citation></ref>
<ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reeves</surname><given-names>A</given-names></name><name><surname>White</surname><given-names>H</given-names></name><name><surname>Sosnowski</surname><given-names>K</given-names></name><name><surname>Tran</surname><given-names>K</given-names></name><name><surname>Jones</surname><given-names>M</given-names></name><name><surname>Palmer</surname><given-names>M</given-names></name></person-group>. <article-title>Energy and protein intakes of hospitalized patients with acute respiratory failure receiving non-invasive ventilation.</article-title> <source>Clin Nutr</source>. <year>2014</year>;<volume>33</volume>:<fpage>1068</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.clnu.2013.11.012</pub-id><pub-id pub-id-type="pmid">24321188</pub-id></mixed-citation></ref>
<ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kogo</surname><given-names>M</given-names></name><name><surname>Nagata</surname><given-names>K</given-names></name><name><surname>Morimoto</surname><given-names>T</given-names></name><etal/></person-group> <article-title>Enteral nutrition is a risk factor for airway complications in subjects undergoing noninvasive ventilation for acute respiratory failure.</article-title> <source>Respir Care</source>. <year>2017</year>;<volume>62</volume>:<fpage>459</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.4187/respcare.05003</pub-id><pub-id pub-id-type="pmid">27923936</pub-id></mixed-citation></ref>
<ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leder</surname><given-names>SB</given-names></name><name><surname>Siner</surname><given-names>JM</given-names></name><name><surname>Bizzaro</surname><given-names>MJ</given-names></name><name><surname>McGinley</surname><given-names>BM</given-names></name><name><surname>Lefton-Greif</surname><given-names>MA</given-names></name></person-group>. <article-title>Oral alimentation in neonatal and adult populations requiring high-flow oxygen via nasal cannula.</article-title> <source>Dysphagia</source>. <year>2016</year>;<volume>31</volume>:<fpage>154</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/s00455-015-9669-3</pub-id><pub-id pub-id-type="pmid">26590570</pub-id></mixed-citation></ref>
<ref id="r33"><label>33</label><mixed-citation publication-type="web">Terzi N, Darmon M, Reignier J, et al. OUTCOMEREA study group. Initial nutritional management during noninvasive ventilation and outcomes: a retrospective cohort study. Crit Care 2017;21:293. Dostupno na: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org./10.1186/s13054-017-1867-y">https://doi.org./10.1186/s13054-017-1867-y</ext-link></mixed-citation></ref>
<ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frat</surname><given-names>JP</given-names></name><name><surname>Thille</surname><given-names>AW</given-names></name><name><surname>Mercat</surname><given-names>A</given-names></name><etal/><collab>FLORALI Study Group</collab></person-group>. <article-title><italic>REVA Network</italic>. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure.</article-title> <source>N Engl J Med</source>. <year>2015</year>;<volume>372</volume>:<fpage>2185</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1503326</pub-id><pub-id pub-id-type="pmid">25981908</pub-id></mixed-citation></ref>
<ref id="r35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>P</given-names></name><name><surname>Rattanachaiwong</surname><given-names>S</given-names></name></person-group>. <article-title>To eat or to breathe? The answer is both! Nutritional management during noninvasive ventilation.</article-title> <source>Crit Care</source>. <year>2018</year>;<volume>22</volume>:<fpage>27</fpage>. <pub-id pub-id-type="doi">10.1186/s13054-018-1947-7</pub-id><pub-id pub-id-type="pmid">29409542</pub-id></mixed-citation></ref>
<ref id="r36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>SJ</given-names></name><name><surname>Tsai</surname><given-names>AA</given-names></name><name><surname>Scala</surname><given-names>CM</given-names></name><name><surname>Sowa</surname><given-names>DC</given-names></name><name><surname>Sheean</surname><given-names>PM</given-names></name><name><surname>Braunschweig</surname><given-names>CL</given-names></name></person-group>. <article-title>Adequacy of oral intake in critically ill patients 1 week after extubation.</article-title> <source>J Am Diet Assoc</source>. <year>2010</year>;<volume>110</volume>:<fpage>427</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.jada.2009.11.020</pub-id><pub-id pub-id-type="pmid">20184993</pub-id></mixed-citation></ref>
<ref id="r37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skoretz</surname><given-names>SA</given-names></name><name><surname>Flowers</surname><given-names>HL</given-names></name><name><surname>Martino</surname><given-names>R</given-names></name></person-group>. <article-title>The incidence of dysphagia following endotracheal intubation: a systematic review.</article-title> <source>Chest</source>. <year>2010</year>;<volume>137</volume>:<fpage>665</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1378/chest.09-1823</pub-id><pub-id pub-id-type="pmid">20202948</pub-id></mixed-citation></ref>
<ref id="r38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macht</surname><given-names>M</given-names></name><name><surname>Wimbish</surname><given-names>T</given-names></name><name><surname>Clark</surname><given-names>B</given-names></name><etal/></person-group> <article-title>Postextubation dysphagia is persistent and associated with poor outcomes in survivors of critical illness.</article-title> <source>Crit Care</source>. <year>2011</year>;<volume>15</volume>:<fpage>R231</fpage>. <pub-id pub-id-type="doi">10.1186/cc10472</pub-id><pub-id pub-id-type="pmid">21958475</pub-id></mixed-citation></ref>
<ref id="r39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macht</surname><given-names>M</given-names></name><name><surname>White</surname><given-names>D</given-names></name><name><surname>Moss</surname><given-names>M</given-names></name></person-group>. <article-title>Swallowing dysfunction after critical illness.</article-title> <source>Chest</source>. <year>2014</year>;<volume>146</volume>:<fpage>1681</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1378/chest.14-1133</pub-id><pub-id pub-id-type="pmid">25451355</pub-id></mixed-citation></ref>
<ref id="r40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuercher</surname><given-names>P</given-names></name><name><surname>Moret</surname><given-names>CS</given-names></name><name><surname>Dziewas</surname><given-names>R</given-names></name><name><surname>Schefold</surname><given-names>JC</given-names></name></person-group>. <article-title>Dysphagia in the intensive care unit: epidemiology, mechanisms, and clinical management.</article-title> <source>Crit Care</source>. <year>2019</year>;<volume>23</volume>:<fpage>103</fpage>. <pub-id pub-id-type="doi">10.1186/s13054-019-2400-2</pub-id><pub-id pub-id-type="pmid">30922363</pub-id></mixed-citation></ref>
<ref id="r41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruser</surname><given-names>JM</given-names></name><name><surname>Prescott</surname><given-names>HC</given-names></name></person-group>. <article-title>Dysphagia after acute respiratory distress syndrome: another lasting legacy of critical illness.</article-title> <source>Ann Am Thorac Soc</source>. <year>2017</year>;<volume>14</volume>:<fpage>307</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1513/AnnalsATS.201612-1040ED</pub-id><pub-id pub-id-type="pmid">28248578</pub-id></mixed-citation></ref>
<ref id="r42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pryor</surname><given-names>L</given-names></name><name><surname>Ward</surname><given-names>E</given-names></name><name><surname>Cornwell</surname><given-names>AO</given-names></name><name><surname>Connor</surname><given-names>S</given-names></name><name><surname>Chapman</surname><given-names>M</given-names></name></person-group>. <article-title>Patterns of return to oral intake and decanulation post tracheotomy across clinical populations in an acute inpatient setting.</article-title> <source>Int J Lang Commun Disord</source>. <year>2016</year>;<volume>51</volume>:<fpage>556</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1111/1460-6984.12231</pub-id><pub-id pub-id-type="pmid">26892893</pub-id></mixed-citation></ref>
<ref id="r43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>S</given-names></name><name><surname>Hatakeyama</surname><given-names>J</given-names></name><name><surname>Kondo</surname><given-names>Y</given-names></name><name><surname>Hifumi</surname><given-names>T</given-names></name><name><surname>Sakuramoto</surname><given-names>H</given-names></name><name><surname>Kawasaki</surname><given-names>T</given-names></name></person-group>. <article-title>Post-intensive care syndrome: its pathophysiology, prevention, and future directions.</article-title> <source>Acute Med Surg</source>. <year>2019</year>;<volume>6</volume>:<fpage>233</fpage>&#x2013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1002/ams2.415</pub-id><pub-id pub-id-type="pmid">31304024</pub-id></mixed-citation></ref>
<ref id="r44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landi</surname><given-names>F</given-names></name><name><surname>Camprubi-Robles</surname><given-names>M</given-names></name><name><surname>Bear</surname><given-names>DE</given-names></name><etal/></person-group> <article-title>Muscle loss: The new malnutrition challenge in clinical practice.</article-title> <source>Clin Nutr</source>. <year>2019</year>;<volume>38</volume>:<fpage>2113</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.clnu.2018.11.021</pub-id><pub-id pub-id-type="pmid">30553578</pub-id></mixed-citation></ref>
<ref id="r45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>C</given-names></name><name><surname>Eddleston</surname><given-names>J</given-names></name><name><surname>McCairn</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Improving rehabilitation after critical illness through outpatient physiotherapy classes and essential amino acid supplement: a randomized controlled trial.</article-title> <source>J Crit Care</source>. <year>2015</year>;<volume>30</volume>:<fpage>901</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcrc.2015.05.002</pub-id><pub-id pub-id-type="pmid">26004031</pub-id></mixed-citation></ref>
<ref id="r46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bear</surname><given-names>DE</given-names></name><name><surname>Langan</surname><given-names>A</given-names></name><name><surname>Dimidi</surname><given-names>E</given-names></name><etal/></person-group> <article-title>&#x03B2;Hydroxy-&#x03B2;-methylbutyrate and its impact on skeletal muscle mass and physical function in clinical practice: a systematic review and meta-analysis.</article-title> <source>Am J Clin Nutr</source>. <year>2019</year>;<volume>109</volume>:<fpage>1119</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1093/ajcn/nqy373</pub-id><pub-id pub-id-type="pmid">30982854</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
